Get started
MarketMoversReport

Rhythm Pharmaceuticals Announces Positive Interim Results

Long
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)  
MarketMoversReport  
NASDAQ:RYTM   Rhythm Pharmaceuticals, Inc.
Beyond Technical Analysis
1
0
beyondta
RYTM: Rhythm Pharmaceuticals, Inc.
2022-07-12 07:00:00 Rhythm Pharmaceuticals Announces Positive Interim Results from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.